The Food and Drug Administration has approved a new drug to treat low sexual drive in women, the only one besides Addyi, which entered the market in 2015.
The drug, to be called Vyleesi, will be sold by AMAG Pharmaceuticals and is intended to be used 45 minutes before sex, via an auto-injector pen that is administered in the thigh or abdomen.
Vyleesi offers an alternative option to Addyi. The injection drug meant to be used 25 to 40 minutes before sex - and lasting up to eight hours - showed statistically significant increases in sexual desire in women who used it during phase 3 clinical trials. The drug stimulates certain receptors in the brain that are believed to be integral to sexual functioning. There were also few side effects: nausea, headache and a mild increase in blood pressure (people with uncontrolled blood pressure should not be taking it).
Information Source nytimes.com, abcnews.go.com
Image Source nytimes.com
No comments:
Post a Comment